Published in Muscle Nerve on January 01, 1990
Autonomic dysfunction in chronic inflammatory demyelinating polyradiculoneuropathy. Neurology (2012) 0.92
Autonomic involvement in subacute and chronic immune-mediated neuropathies. Autoimmune Dis (2013) 0.80
Autonomic function in Friedreich's ataxia. J Neurol Neurosurg Psychiatry (1991) 0.75
Progressive polyradiculoneuropathy in diabetes: correlation of variables and clinical outcome after immunotherapy. J Neurol Neurosurg Psychiatry (1999) 0.75
Methods for the separation, purification and measurement of nine components of hemolytic complement in guinea-pig serum. Immunochemistry (1966) 15.12
Three naturally-occurring inhibitors of components of complement in guinea pig and rabbit serum. J Immunol (1967) 3.86
Positional cloning of a gene for Hermansky-Pudlak syndrome, a disorder of cytoplasmic organelles. Nat Genet (1996) 2.47
The sympathetic nervous system in diabetic neuropathy. A clinical and pathological study. Brain (1975) 2.20
Dwarfism and early death in mice lacking C-type natriuretic peptide. Proc Natl Acad Sci U S A (2001) 1.99
The epidemiology of multiple sclerosis in three Australian cities: Perth, Newcastle and Hobart. Brain (1988) 1.98
Chronic inflammatory demyelinating polyradiculoneuropathy. A clinical and electrophysiological study of 92 cases. Brain (1987) 1.98
Chronic relapsing polyneuritis. J Neurol Sci (1976) 1.94
An experimental study of the F wave in the baboon. J Neurol Neurosurg Psychiatry (1966) 1.85
Conduction velocity and fibre diameter of the median and ulnar nerves of the baboon. J Neurol Neurosurg Psychiatry (1967) 1.84
An electrophysiological and pathological study of peripheral nerves in Friedreich's ataxia. J Neurol Sci (1971) 1.78
The purification and reactivity of the first component of complement from guinea pig, human and canine sera. J Immunol (1968) 1.71
Tricorn protease--the core of a modular proteolytic system. Science (1996) 1.71
Vascular endothelial growth factor (VEGF) expression in human coronary atherosclerotic lesions: possible pathophysiological significance of VEGF in progression of atherosclerosis. Circulation (1998) 1.69
Electrophysiological studies in the Guillain-Barré syndrome. Ann Neurol (1981) 1.63
Treatment of multiple sclerosis with the monoclonal anti-CD4 antibody cM-T412: results of a randomized, double-blind, placebo-controlled, MR-monitored phase II trial. Neurology (1997) 1.60
Molecular cloning of the complementary DNA and gene that encode mouse brain natriuretic peptide and generation of transgenic mice that overexpress the brain natriuretic peptide gene. J Clin Invest (1994) 1.60
Human obese gene expression. Adipocyte-specific expression and regional differences in the adipose tissue. Diabetes (1995) 1.58
The mechanism of action of decay-accelerating factor (DAF). DAF inhibits the assembly of C3 convertases by dissociating C2a and Bb. J Exp Med (1987) 1.55
Natriuretic peptide regulation of endochondral ossification. Evidence for possible roles of the C-type natriuretic peptide/guanylyl cyclase-B pathway. J Biol Chem (1998) 1.54
Disorders of the autonomic nervous system: Part 1. Pathophysiology and clinical features. Ann Neurol (1987) 1.52
Chronic polyneuropathy of undetermined cause. J Neurol Neurosurg Psychiatry (1984) 1.51
A frame shift mutation in the PMP22 gene in hereditary neuropathy with liability to pressure palsies. Nat Genet (1994) 1.47
Difference in direct charge-parity violation between charged and neutral B meson decays. Nature (2008) 1.46
Autonomic function in hereditary motor and sensory neuropathy (Charcot-Marie-Tooth disease) Muscle Nerve (1991) 1.46
Genetic models reveal that brain natriuretic peptide can signal through different tissue-specific receptor-mediated pathways. Endocrinology (2000) 1.45
The contribution of mortality statistics to the study of multiple sclerosis in Australia. J Neurol Neurosurg Psychiatry (1989) 1.44
An incompatibility in the reaction of the second component of human complement with the fourth component of guinea-pig complement. Immunology (1970) 1.44
Daily morning hemifacial spasm in a patient with cluster headache. Cephalalgia (2006) 1.44
Digital nerve conduction in the carpal tunnel syndrome after mechanical stimulation of the finger. J Neurol Neurosurg Psychiatry (1966) 1.42
Alcoholic neuropathy. An electrophysiological and histological study. J Neurol Sci (1970) 1.41
Recurrent episodes of confusion, headache and visual disturbance in a young woman. Med J Aust (1993) 1.39
Biased accumulation of T lymphocytes with "memory"-type CD45 leukocyte common antigen gene expression on the epithelial surface of the human lung. J Exp Med (1990) 1.37
Spinal root and plexus hypertrophy in chronic inflammatory demyelinating polyneuropathy. Brain (1999) 1.34
Skeletal overgrowth in transgenic mice that overexpress brain natriuretic peptide. Proc Natl Acad Sci U S A (1998) 1.34
The soluble CD40 ligand sCD154 in systemic lupus erythematosus. J Clin Invest (1999) 1.33
Osteopontin/Eta-1 upregulated in Crohn's disease regulates the Th1 immune response. Gut (2005) 1.33
Autonomic dysfunction in Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry (1981) 1.32
Peripheral neuropathy associated with mitochondrial myopathy. Ann Neurol (1986) 1.32
The age-range of risk of developing multiple sclerosis: evidence from a migrant population in Australia. Brain (2000) 1.28
Molecular cloning of rat leptin receptor isoform complementary DNAs--identification of a missense mutation in Zucker fatty (fa/fa) rats. Biochem Biophys Res Commun (1996) 1.27
Disorders of the autonomic nervous system: Part 2. Investigation and treatment. Ann Neurol (1987) 1.24
Gian axonal neuropathy--a generalized disorder of cytoplasmic microfilament formation. J Neuropathol Exp Neurol (1976) 1.23
Electrophysiological studies in familial spastic paraplegia. J Neurol Neurosurg Psychiatry (1977) 1.23
Acute idiopathic polyneuritis. A clinical and electrophsiological follow-up study. J Neurol Sci (1976) 1.22
Multiple sclerosis in Australia and New Zealand: are the determinants genetic or environmental? J Neurol Neurosurg Psychiatry (1990) 1.22
Distal type of chronic spinal muscular atrophy. Clinical, electrophysiological and pathological studies. Brain (1971) 1.22
The ninth component of guinea-pig complement. Isolation and identification as an alpha 2-globulin. Immunology (1971) 1.21
Charcot-Marie-Tooth disease with Leber optic atrophy. Neurology (1978) 1.21
Distal chronic spinal muscular atrophy involving the hands. J Neurol Neurosurg Psychiatry (1978) 1.21
Idiopathic pure sudomotor failure: anhidrosis due to deficits in cholinergic transmission. Neurology (2004) 1.21
Mutation analysis of patients with Hermansky-Pudlak syndrome: a frameshift hot spot in the HPS gene and apparent locus heterogeneity. Am J Hum Genet (1998) 1.20
Interaction of C3 with antigen-antibody complexes in the process of solubilization of immune precipitates. J Immunol (1984) 1.20
The sympathetic nervous system in alcoholic neuropathy. A clinical and pathological study. Brain (1975) 1.20
Friedreich's ataxia. Early detection and progression of peripheral nerve abnormalities. J Neurol Sci (1982) 1.20
HLA family studies and multiple sclerosis: A common gene, dominantly expressed. Hum Immunol (1981) 1.19
Abnormalities of insulin secretion in dystrophia myotonica. Brain (1970) 1.18
Solubilization of immune precipitates by six isolated alternative pathway proteins. J Exp Med (1981) 1.18
Isolation and characterization of CA XIV, a novel membrane-bound carbonic anhydrase from mouse kidney. J Biol Chem (1999) 1.18
Evoked potential changes in clinically definite multiple sclerosis: a two year follow up study. J Neurol Neurosurg Psychiatry (1982) 1.17
Characterization of three monoclonal antibodies against C3 with selective specificities. Immunology (1987) 1.17
Ulnar nerve lesions associated with the carpal tunnel syndrome. J Neurol Neurosurg Psychiatry (1973) 1.15
Molecular cloning of rat obese cDNA and augmented gene expression in genetically obese Zucker fatty (fa/fa) rats. J Clin Invest (1995) 1.15
Optically active antifungal azoles. VI. Synthesis and antifungal activity of N-[(1R,2R)-2-(2,4-difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazo l-1- yl)propyl]-N'-(4-substituted phenyl)-3(2H,4H)-1,2,4-triazolones and 5(1H,4H)-tetrazolones. Chem Pharm Bull (Tokyo) (1996) 1.14
Further evidence for immune cytolysis by antibody and the first eight components of complement in the absence of C9. Immunology (1972) 1.12
Hypothyroid polyneuropathy. Clinical, electrophysiological and nerve biopsy findings in two cases. J Neurol Sci (1982) 1.12
HLA antigens in the Landry-Guillain-Barré syndrome and chronic relapsing polyneuritis. Ann Neurol (1978) 1.10
Organization, structure, chromosomal assignment, and expression of the gene encoding the human endothelin-A receptor. J Biol Chem (1992) 1.09
Vasculitis confined to peripheral nerves. Brain (1996) 1.09
Hepatitis C virus infection and membranoproliferative glomerulonephritis in Japan. J Am Soc Nephrol (1995) 1.08
Complement-mediated solubilization of immune complexes in systemic lupus erythematosus. Clin Exp Immunol (1982) 1.08
Observation of long-distance radial correlation in toroidal plasma turbulence. Phys Rev Lett (2011) 1.08
Classification of neuromuscular disorders. J Neurol Sci (1994) 1.08
Class II antigen expression and T lymphocyte subsets in chronic inflammatory demyelinating polyneuropathy. J Neuroimmunol (1986) 1.08
Chromosome I linkage studies in Charcot-Marie-Tooth neuropathy type I. Am J Hum Genet (1988) 1.07
Peripheral neuropathy following a single exposure to arsenic. Clincal course in four patients with electrophysiological and histological studies. J Neurol Sci (1977) 1.07
Chronic inflammatory demyelinating polyradiculoneuropathy associated with pregnancy. Ann Neurol (1987) 1.06
Extended mapping and exploration of the vanadium dioxide stress-temperature phase diagram. Nano Lett (2010) 1.06
Observation of reduced heat transport inside the magnetic island O point in the large helical device. Phys Rev Lett (2004) 1.06
The epidemiology of multiple sclerosis in Queensland, Australia. J Neurol Sci (1987) 1.06
Hypertrophic Charcot-Marie-Tooth disease. Light and electron microscope studies of the sural nerve. J Neurol Sci (1978) 1.06
Centronuclear myopathy with autosomal dominant inheritance. J Neurol Sci (1972) 1.06
A case of plasmacytosis with multiple peculiar eruptions. J Dermatol (1980) 1.05
Cysteine-scanning mutagenesis of transmembrane segments 4 and 5 of the Tn10-encoded metal-tetracycline/H+ antiporter reveals a permeability barrier in the middle of a transmembrane water-filled channel. J Biol Chem (2000) 1.03
Serum cardiac troponin T in polymyositis/dermatomyositis. Lancet (1992) 1.03
Interaction of C4-binding protein with cell-bound C4b. A quantitative analysis of binding and the role of C4-binding protein in proteolysis of cell-bound C4b. J Exp Med (1983) 1.01
Shear stress augments expression of C-type natriuretic peptide and adrenomedullin. Hypertension (1997) 1.01
A spinocerebellar degeneration with X-linked inheritance. Brain (1979) 1.01
Hereditary demyelinating neuropathy in the trembler mouse. J Neurol Sci (1975) 1.01
Clinical syndromes associated with tomacula or myelin swellings in sural nerve biopsies. J Neurol Neurosurg Psychiatry (2000) 1.01
The clinical profile of MS in Australia: a comparison between medium- and high-frequency prevalence zones. Neurology (1988) 1.00
Cyclosporin A in resistant chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve (1998) 1.00
Structural organization and chromosomal assignment of the human obese gene. J Biol Chem (1995) 1.00
Activated non-neural specific T cells open the blood-brain barrier to circulating antibodies. Brain (1999) 1.00
Characterization of the 5'-flanking region and chromosomal assignment of the human brain natriuretic peptide gene. J Mol Med (Berl) (1995) 0.99
Class II antigen expression and inflammatory cells in the Guillain-Barré syndrome. Ann Neurol (1987) 0.98
Vincristine neuropathy: an electrophysiological and histological study. J Neurol Neurosurg Psychiatry (1969) 0.98
Peripheral neuropathy in spinocerebellar degenerations. Muscle Nerve (1981) 0.97